Interferon Beta-1a for Multiple Sclerosis from Japan
Interferon Beta-1a is a recombinant human protein used to manage relapsing multiple sclerosis. It is produced through biotechnological processes and acts as an immunological product that regulates immune responses. This places it under tariff item 3002.90.00, which covers other blood fractions and immunological products.
Duty Rate — Japan → Canada
0%
Import Tips
• Ensure the product is accompanied by a valid Drug Identification Number (DIN) from Health Canada
• Declare the biological nature of the product to the CBSA to avoid delays
• Keep records of the biotechnological production process to support classification